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Summary
Replication of eukaryotic genomes is limited to once per cell
cycle, by a two-step mechanism [1, 2]. DNA replication
origins are first ‘‘licensed’’ during G1 phase by loading of
an inactive DNA helicase (Mcm2-7) into pre-replicative
complexes (pre-RCs). Initiation then occurs during S phase,
triggered by cyclin-dependent kinases (CDKs), which
promote recruitment of proteins required for helicase activa-
tion and replisome assembly [3, 4]. CDKs and the anaphase
promoting complex/cyclosome (APC/C) restrict licensing to
G1 phase by directly and indirectly regulating pre-RC
components [2], including ORC, Cdc6, Cdt1, and Mcm2-7.
Despite the fundamental importance of licensing regulation,
themechanisms by which pre-RC components are regulated
differ widely across Eukarya. Here we show that even within
the genus Saccharomyces, Cdc6 is regulated differently in
different species. We propose that two factors contribute
to the rapid evolution of licensing regulation. The first is
redundancy: eliminating any single pre-RC-regulatory
mechanism has very little affect on viability. The second is
interchangeability: we show that regulatory mechanisms
can be swapped between pre-RC components without
compromising the block to re-replication. These experi-
ments provide a framework for understanding the diversity
of licensing regulation in eukaryotes and provide new tools
for manipulating the chromosome-replication cycle.
Results and Discussion
Comparison of Cdc6 Regulation in Saccharomyces
Species
We began to study licensing-control variation in Saccharo-
myces species by examining the Cdc6 protein. In S.cerevisiae,
active Cdc6 protein is present in cells only during early G1
phase [5–7]. This is because cyclin-dependent kinases
(CDKs) inhibit Cdc6 protein by several mechanisms. First,
CDKs regulate Cdc6 stability [6–9] by direct phosphorylation
of Cdc6, targeting it for ubiquitin-mediated proteolysis. From
late G1 phase through S phase, Cdc6 is very rapidly degraded,
which we have previously termed ‘‘mode 2’’ degradation [8, 9].
This rapid proteolysis occurs because CDK phosphorylation
generates two separate, functional binding sites for Cdc4, an
F box-containing substrate-recognition subunit of the SCF
ubiquitin ligase (Figure S1, available online). One of these
Cdc4 binding sites lies within a 50 amino acid N-terminal regu-
latory domain (NTD). The second site lies within a C-terminal
regulatory domain (CTD) located downstream of the sensor II*Correspondence: john.diffley@cancer.org.ukmotif in the AAA+ domain [8, 9]. Cdc6 is also inhibited by direct
interaction between the mitotic cyclin Clb2 and the NTD [10,
11]. This binding requires phosphorylation of the NTD and
inhibits Cdc6 by preventing it from being recruited to ORC
[10]. Clb2 binding also prevents interaction between Cdc6
and Cdc4, which causes partial stabilization of Cdc6 during
mitosis [10]. The Cdc4 binding site in the CTD remains acces-
sible during mitosis and is responsible for the slower proteol-
ysis at this time (‘‘mode 3’’ degradation). Clb2 in yeast acts
analogously to geminin in metazoans: both bind to and inhibit
essential licensing factors (Cdc6 and Cdt1, respectively) [1],
both are APC/C substrates [12, 13], and both stabilize their
partners during mitosis by inhibiting ubiquitin-mediated prote-
olysis [10, 14].
We examined Cdc6 protein from five Saccharomyces
species. Three of these, S.cerevisiae, S.bayanus, and
S.kudriavzevii, are closely related (sensu stricto), whereas
S.castellii and S.kluyveri are more distantly related (sensu
lato) [15, 16]. All five Cdc6 proteins are functional in S.cerevi-
siae, efficiently complementing a cdc6 temperature-sensitive
mutant (Figure S2A). Although the AAA+ domain is highly
conserved among all of these yeasts, Figure S1B shows that
the regulatory domains are not well conserved outside of the
sensu stricto yeasts. Within the NTD, all of the Cdc6 proteins
contain multiple CDK consensus sites: four in all of the sensu
stricto Cdc6 proteins, three in S.castellii Cdc6, and five in
S.kluyveri Cdc6. The positions and arrangement of these sites
do not appear to be conserved; however, all of the yeasts
contain a sequence related to the S.cerevisiae Cdc4 interac-
tion motifs (S/TPXX
S/TPX
K/R) in the NTD [9]. The CDK
consensus sites within the CTD are conserved within the sensu
stricto Cdc6 proteins but are absent from S.castellii and
S.kluyveri Cdc6 proteins.
To determine whether any of these proteins could bind
Cdc4, we used a yeast two-hybrid assay. Figure 1A shows
that the NTD (see Figure S2B for sequences) from all five yeast
Cdc6 proteins interacted with Cdc4, using activation of lacZ
and HIS3 reporter genes as readout for interaction. The
CTDs from all of the sensu stricto yeast proteins interacted
with Cdc4; however, this region from the sensu lato Cdc6
proteins did not interact with Cdc4, consistent with the fact
that these proteins lack CDK consensus sites. Figure 1B
shows that all five Cdc6 proteins are unstable in nocodazole-
arrested cells and all five proteins are stabilized after inactiva-
tion of Cdc4 with the use of a cdc4 temperature-sensitive
mutant. The levels of the sensu lato Cdc6 proteins were lower
than those of the sensu stricto proteins after galactose induc-
tion, suggesting that they might be more unstable in nocoda-
zole-arrested cells. Next, we examined Cdc6 levels during
the cell cycle under conditions in which Cdc6 is transcribed
constitutively. To do this, we performed an alpha factor block
and release into galactose-containing medium, using strains in
which each CDC6 gene was driven by the GAL1,10 promoter.
Figure 1C shows that Cdc6 proteins from S.cerevisiae, S.baya-
nus, and S.castellii all disappear sharply 20–30 min after
release, as cells enter S phase. This is consistent with very
rapid degradation (mode 2) previously described for S.cerevi-
siae Cdc6 protein [8]. In both the sensu stricto yeasts
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Figure 1. Regulation of Yeast Cdc6 Proteins by SCFCDC4
(A) Yeast two-hybrid assay used in testing for interaction between Cdc4 and
Cdc6 proteins. Two-hybrid constructs containing the putative N terminal
(NTD) or C-terminal (CTD) Cdc4 interaction domains of Cdc6 from each
yeast species (see Figure S2B) were assayed for transcriptional activation
of the LacZ and the HIS3 genes in the presence of either the empty pAct
vector or pAct containing a fragment of Cdc4 fused to the GAL activation
domain [6]. Yeast species are termed as follows for brevity: S.cer (S.cerevi-
siae), S. bay (S.bayanus), S.kud (S.kudriavzevii), S. cas (S.castellii), and S.klu
(S.kluyveri).
(B) Cdc4-dependent proteolysis. Cells were arrested in G2/M with nocoda-
zole and then raised to the restrictive temperature at the same time that
expression of the Cdc6s was induced from the GAL1,10 promoter, for
30 min. At time 0, transcription and translation were prevented with glucose
and cycloheximide, respectively. Samples were taken at the indicated time
points and processed for immunoblotting. 9E10 was used for detecting the
Cdc6-13myc proteins.
(C) Rapid degradation in G1/S phase. Cdc6 from S.bayanus and S.castellii
was compared with Cdc6 from S.cerevisiae for examination of the rapid
degradation previously described as mode 2 [8]. Cells were synchronised
in G1 with alpha factor and then released back into the cell cycle in medium
containing galactose, so that the Cdc6 proteins were expressed(S.cerevisiae and S.bayanus), Cdc6 reaccumulates 70–90 min
after release, consistent with the slower mode 3 degradation.
In S.castellii, however, Cdc6 levels remain low in G2/M, sug-
gesting that its degradation does not slow significantly after
S phase.
The apparent absence of the slower mode 3 degradation in
S.castellii Cdc6 suggested that it might not bind to the mitotic
cyclin Clb2. Overexpression of the sensu stricto Cdc6 proteins
inhibited growth and induced an elongated-bud phenotype
consistent with Clb2 inhibition (Figure 2A). However, overex-
pression of the two sensu lato Cdc6 proteins had no effect
on cell growth or bud morphology, consistent with the possi-
bility that they do not inhibit Clb2. To examine this directly,
we performed reciprocal immunoprecipitations of Cdc6 and
Clb2 proteins. Figure 2B shows that the sensu stricto Cdc6
proteins all immunoprecipitate efficiently with Clb2, whereas
neither of the sensu lato proteins showed efficient Clb2
binding. To examine whether this is because of species-
specific protein-protein interactions that might be lost in this
heterologous system, we expressed the S.castellii Clb2 in
the strain expressing the S.castellii Cdc6. Figure 2C shows
that no interaction between these proteins was detected in
extracts. Thus, in contrast to S.cerevisiae Cdc6, S.castellii
Cdc6 does not appear to interact with its cognate Clb2 protein.
Taken together, these experiments indicate that all of the
sensu stricto Cdc6 proteins have two Cdc4 binding sites:
one in the NTD and one in the CTD. The sensu lato proteins,
however, have a Cdc4 binding site only in the NTD. All of the
sensu stricto proteins bind Clb2, which appears to stabilize
the protein in G2/M, whereas the sensu lato proteins do not
bind Clb2. This suggests that the ability of the NTD to bind
Clb2 may necessitate the presence of a second Cdc4 targeting
sequence. Consistent with this, we have previously shown that
in the CTD of Cdc6, a mutation that eliminates Cdc4 interaction
is dominant negative [9]. This dominant-negative phenotype is
caused by Clb2 binding and can be suppressed by deletion of
the NTD. These experiments indicate that the regulation of the
Cdc6 protein appears to have diverged within the genus
Saccharomyces.
This led us to consider factors that might promote rapid
evolution of licensing control. One likely factor is redundancy:
CDKs prevent re-replication through multiple mechanisms.
Cells expressing Cdc6 lacking the NTD are viable and have
apparently normal DNA replication [6], and strains in which
either ORC or Mcm2-7 have been deregulated individually
are also viable [17]. Although loss of both ORC and Cdc6 regu-
lation is lethal [10, 18], strains in which both Cdc6 and Mcm2-7
have been deregulated are viable (Figure S3A). Thus, there is
considerable functional redundancy in these regulatory mech-
anisms.
Interchangeable Regulatory Mechanisms
CDKs inhibit pre-RC components by three general mecha-
nisms: targeted proteolysis, nuclear exclusion, and direct
binding. A second factor that might contribute to rapid evolu-
tion would be the potential for interchangeability; that is, the
possibility that in a single organism, re-replication could be
prevented by regulation of any pre-RC component by any of
constitutively. Samples were taken at the time of release (T0) and then every
10 min afterwards, for 90 min, and processed for immunoblotting and flow
cytometry (FACS). LC represents the Ponceau S stained membrane used
as a loading control. The FACS profiles are shown on the right side of the
panel. The gray shaded profiles at 30 and 40 min in each case indicate
when the cells are in S phase.
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we asked whether we could effectively change the mechanism
by which individual licensing factors are regulated in S.cerevi-
siae. CDKs do not directly regulate Cdt1 in budding yeast:
Cdt1 levels are constant during the cell cycle and, although
Cdt1 nuclear localization is regulated during the cell cycle,
this regulation appears to occur passively via interactions
with Mcm2-7 [19]. To confer CDK regulation onto Cdt1, we
fused the N-terminal 214 amino acids from the CDK inhibitor
Sic1 onto the N terminus of Cdt1 and expressed this as the
sole copy of Cdt1 from the endogenous CDT1 (TAH11)
promoter. This N-terminal domain of Sic1 lacks its CDK inhib-
itory activity, but contains multiple CDK phosphorylation sites
that target it for SCFCDC4-dependent proteolysis [20].
Figure 3A (and Figure S3B) shows that this fusion protein
(Cdt1-d), like the wild-type Cdt1, is stable in alpha-factor-ar-
rested cells. However, in contrast to wild-type Cdt1 (but similar
to wild-type Sic1), it is unstable in nocodazole-arrested cells
(Figure 3A). It is also degraded approximately 20–30 min after
release from an alpha-factor block, similar to both Cdc6 and
A
B
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Figure 2. Interaction of Cdc6 Proteins with Clb2
(A) Morphology of S.cerevisiae cells expressing
Cdc6 proteins. W303-1a was transformed with
Cdc6 from each species under the control of the
GAL1,10 promoter. The cells were grown on
galactose-containing plates and examined by
microscopy.
(B) Interaction between Clb2 and Cdc6 proteins.
Coimmunoprecipitation experiments were per-
formed on extracts of yeast expressing GAL1,10
Cdc6 proteins (see Experimental Procedures)
for investigation of any interaction with Clb2. A
sample was mock treated (-ab) as a control. After
SDS-PAGE and western-blot transfer, the
membrane was divided into three strips, accord-
ing to MW range, for detection of Cdc6-13Myc,
Clb2, and Cdc28. Control immunoprecipitations
were performed on extracts made from the
same strains incubated in glucose (no expression
of GAL1,10 Cdc6 proteins). The supernatants
after depletion (Sup) are shown on the left side
of each panel, and the immunoprecipitiations
(IP) are shown on the right side.
(C)S.castelliiClb2 interaction with Cdc6. The ORF
of Clb2 (with a 4xHA N-terminal tag) from S.cas-
tellii was expressed under the control of the
GAL1,10 promoter in strains also containing
either GAL1,10 Cdc6 from S.cerevisiae or
GAL1,10 Cdc6 from S.castellii. Extracts were
made from asynchronous cultures grown either
in YPD, as a control, or YPGal. Each extract was
split into three and treated for immunoprecipita-
tion of Clb2 or Cdc6 or mock treated with no anti-
body. The supernatants and the immunoprecipi-
tates were processed for immunoblotting.
Sic1 (Figure S3C). Thus, budding yeast
Cdt1 can be regulated by SCF-depen-
dent, cell-cycle-regulated proteolysis
without affecting viability.
Deregulation of ORC, Cdc6, and
Mcm2-7 in G2/M-arrested cells induces
substantial amounts of re-replication
[17]. Figure 3B shows that replacement
of wild-type Cdt1 with the Sic1-Cdt1
fusion protein suppressed this re-
replication. Moreover, this fusion protein also suppressed
much of the lethality associated with this re-replication
(Figure 3C).
We then asked whether Sic1-Cdt1 could contribute to
prevention of re-replication and promotion of viability over
a longer period of time. Expression of Cdc6 lacking the NTD
(Cdc6DNT) is lethal in cells expressing deregulated Orc2 and
Orc6 [10] [18]. Figure 3D shows that this lethality was sup-
pressed when wild-type Cdt1 was replaced with the Sic1-
Cdt1 fusion protein. Thus, this heterologous fusion protein
appears capable of participating effectively in preventing re-
replication during sustained growth.
To provide an additional example of interchangeability, we
replaced the NTD of Cdc6 with a cassette containing a bipartite
nuclear localization sequence from Mcm2 and Mcm3 (NLS) and
a nuclear export sequence (NES) from Mcm3. This cassette has
been shown to confer cell-cycle-regulated nuclear localization
on heterologous proteins [21]. The Mcm3 NES is regulated by
CDK phosphorylation, so we also made a construct in which
CDK regulation of this NES has been eliminated (nes), resulting
Diversity in the Regulation of Pre-RC Assembly
533A
B C
D
E
Figure 3. Interchanging Regulatory Mechanisms of Pre-RC
Proteins
(A) Stability of the Cdt1-d fusion protein in G1 and G2/M.
W303-1a cells and YLD117 (Cdt1-d as the only copy of
Cdt1) were synchronised either in G1 with alpha factor or
G2/M with nocodazole. Cycloheximide was added at T0,
and samples were taken at the times indicated and pro-
cessed for immunoblotting. Cdt1 and Cdt1-d were detected
with a Cdt1 polyclonal antibody.
(B) Deregulated Cdt1 suppresses re-replication in G2/M.
Cdt1 was replaced with Cdt1-d in the MCM7-NLS, orc2-6A,
orc6-4A strain containing either GAL1,10 Cdc6 (YST256) or
GAL1,10 Cdc6DNT (YST257) for creation of strains YLD118
and YLD119, respectively. Cells were arrested in G2/M, and
the Cdc6 proteins were induced with galactose at the indi-
cated times. The FACS profile for each strain is shown at
the time of induction and at 1 hr intervals afterwards for up
to 4 hr. Samples were taken and processed for confirming
induction of Cdc6 (Figure S3D).
(C) Deregulated Cdt1 rescues the loss of viability caused by
re-replication. Cells were plated on glucose plates at the start
and end point of the re-replication assay described above for
assessment of their viability. Cell number at 4 hr is expressed
as a percentage of cell number at 0 hr for each respective
strain.
(D) Cdt1-d suppresses the lethality caused by expressing
Cdc6DNT in orc2-6A, orc6-4A cells. Cdt1 was replaced by
Cdt1-d in the orc2-6A, orc6-4A strain (YLD124 and
YJL1737, respectively). Both strains were transformed with
an equal amount of vector control or plasmids expressing
the indicated Cdc6 proteins from theCDC6 promoter. Colony
numbers were counted after 3 days (see plates) and are
expressed in the histogram as percentage of transformants
compared with the vector control.
(E) Regulated Cdc6DNT is not lethal in orc2-6A, orc6-4A
cells. A346a (ORC) and YJL1737 (orc2-6A, orc6-4A) were
transformed with plasmids expressing the indicated Cdc6
proteins from the CDC6 promoter, similar to the assay
described above. N/N is Cdc6DNT with a NLS/NES cassette
fused to the N terminus (see main text and Experimental
Procedures), whereas N/n has a mutant nes.in constitutive nuclear localization. Figure 3E shows that, in
contrast to Cdc6DNT, Cdc6DNT fused to the wild-type NLS/
NES is viable in a background containing deregulated Orc2
and Orc6. This viability requires the CDK regulation of the
NES. Thus, CDK-regulated nuclear exclusion can effectively
be transferred from Mcm2-7 to Cdc6. Taken altogether, these
experiments indicate that regulatory mechanisms can be effec-
tive in maintaining cell viability and preventing re-replication
when swapped between pre-RC components.
Our experiments provide additional evidence that the regula-
tion of licensing control has evolved relatively rapidly. Previous
work showed that the cell-cycle regulation of Mcm2-7 nuclear
localization, conserved in both sensu stricto and sensu lato
Saccharomyces species, was acquired after divergence of
the lineage leading to Candida albicans [22]. Our results indi-
cate that the inhibition of Cdc6 by both Clb2 binding to the
NTD and Cdc4 binding to the CTD was acquired even more
recently in the lineage leading to the sensu stricto species.
Although the binding of Clb2 to Cdc6 is specific for a relatively
narrow group of budding yeasts, we note that the ability of
mitotic cyclins to bind specifically to phosphorylated peptides,
including the NTD of S.cerevisiaeCdc6, has been conserved in
eukaryotic evolution between yeast and humans [10, 23].We previously suggested that redundancy provides a key
driving force in the evolution of licensing control [2]. Because
no single mechanism for inhibiting pre-RC components can
be completely effective, multiple mechanisms are required
for achievement of an efficient block to re-replication (Figure 4).
However, as the number of inhibitory mechanisms increases,
the relative importance of any single mechanism decreases.
During evolution, these regulatory mechanisms may be gained
or lost, and an organism may ‘‘sit’’ at different positions along
the curve in Figure 4. We suggest that budding yeast is rela-
tively far to the right on this curve: the single loss of Cdc6,
Mcm2-7, or ORC regulation has little effect on growth, at least
in the short term. Fission yeast, however, may have a less rich
assortment of these mechanisms and appears to be more
sensitive to the loss of any single mechanism: overexpression
of Cdc6/18 is sufficient to induce extensive re-replication [24].
The appearance of geminin in metazoa provides an additional
mechanism for preventing re-replication, which may have
been important in supporting an increase in genome size.
In this paper, we have shown that re-replication can be
effectively prevented when inhibitory mechanisms are swap-
ped between pre-RC proteins. We propose that this feature
contributes to the rapid evolution of licensing control. As we
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evolved additional functions in cells unrelated to DNA replica-
tion, and this may put some constraints on how any individual
pre-RC component might be regulated in any particular
organism.
Experimental Procedures
Strains and Constructs
All strains used were derived from W303-1a (MATa ade2-1 ura3-1 his3-11,15
trp1-1 leu2-3,112 can1-100), except for the strains used in the re-replication
and transformation assay; these were derived from A364a (Mat a, ade1,
ade2, ura1, his7, lys2, tyr1, gal1). For full description of strains and
constructs, see Supplemental Data (available online).
Yeast Techniques
A yeast two-hybrid analysis was performed as described previously [6], with
the use of the yeast strain L40 and the bait and prey plasmids BTM116 and
pACT. Transcriptional activation was measured on plates containing X-GAL
and on minimal media plates supplemented for the required amino acids but
lacking histidine.
Media, cell-cycle experiments, and GAL1,10 promoter shut-off experi-
ments have been described previously [6, 9].
Re-replication assays and the transformation assay were performed as
previously described [10].
Samples for flow cytometry were collected and processed as described
previously [25]. Analysis was performed with a Becton Dickinson FACScan.
Immunoprecipitation and Immunoblotting
Extracts from asynchronous cultures for use in immunoprecipitation were
performed as previously described [10]. 9E11 was used for immunoprecipi-
tating Cdc6 13xMyc proteins. sc-9071 (Insight Biotechnologies) was used
for immunoprecipitating Clb2. 4xHA Clb2 from S.castellii was immunopre-
cipitated with the 12CA5 monoclonal antibody.
Protein extracts and immunoblotting were performed as described previ-
ously [8]. Monoclonal antibody 9H/8 was used for detecting Cdc6 and
Cdc6DNT [6]. 9E10 was used for detecting 13xMyc-tagged Cdc6 proteins.
sc-9071 (Insight Biotechnologies) was used for detecting Clb2. Anti-PSTAIR
antibody was used for detecting Cdc28 (a gift from J. Gannon) at 1:10,000.
JDI 70 polyclonal antibody was used for detecting Cdt1 and Cdt1-d. Sic1
was detected with JDI 53 polyclonal antibody. Protein A-HRP (GE Health-
care Biosciences), anti mouse IgG-HRP (Vector Labs), or anti goat IgG-
HRP (Insight Biotechnologies) were used as secondary antibodies at
1:5000, as appropriate.
Supplemental Data
Supplemental data include Supplemental Experimental Procedures, three
figures, and one table and can be found with this article online at http://
www.current-biology.com/supplemental/S0960-9822(09)00743-X.
Figure 4. Model: The Evolution of Multiple Pre-RC-Regulatory Pathways
Details of the model are described in the main text.Acknowledgments
We thank Joachim Li for strains and plasmids, Ed Louis and Mike Tyers for
yeast strains, and members of the Diffley Laboratory for helpful discussions.
This work was supported by Cancer Research UK.
Received: November 4, 2008
Revised: January 16, 2009
Accepted: February 10, 2009
Published online: March 12, 2009
References
1. Blow, J.J., and Dutta, A. (2005). Preventing re-replication of chromo-
somal DNA. Nat. Rev. Mol. Cell Biol. 6, 476–486.
2. Diffley, J.F.X. (2004). Regulation of early events in chromosome replica-
tion. Curr. Biol. 14, R778–R786.
3. Zegerman, P., and Diffley, J.F.X. (2007). Phosphorylation of Sld2 and
Sld3 by cyclin-dependent kinases promotes DNA replication in budding
yeast. Nature 445, 281–285.
4. Tanaka, S., Umemori, T., Hirai, K., Muramatsu, S., Kamimura, Y., and
Araki, H. (2007). CDK-dependent phosphorylation of Sld2 and Sld3 initi-
ates DNA replication in budding yeast. Nature 445, 328–332.
5. Piatti, S., Lengauer, C., and Nasmyth, K. (1995). Cdc6 is an unstable
protein whose de novo synthesis in G1 is important for the onset of S
phase and for preventing a ‘reductional’ anaphase in the budding yeast
Saccharomyces cerevisiae. EMBO J. 14, 3788–3799.
6. Drury, L.S., Perkins, G., and Diffley, J.F. (1997). The Cdc4/34/53 pathway
targets Cdc6p for proteolysis in budding yeast. EMBO J. 16, 5966–5976.
7. Elsasser, S., Chi, Y., Yang, P., and Campbell, J.L. (1999). Phosphoryla-
tion controls timing of Cdc6p destruction: A biochemical analysis. Mol.
Biol. Cell 10, 3263–3277.
8. Drury, L.S., Perkins, G., and Diffley, J.F.X. (2000). The cyclin dependent
kinase Cdc28p regulates distinct modes of Cdc6p proteolysis during
the budding yeast cell cycle. Curr. Biol. 10, 231–240.
9. Perkins, G., Drury, L.S., and Diffley, J.F.X. (2001). Separate SCFCDC4
recognition elements target Cdc6 for proteolysis in S phase and mitosis.
EMBO J. 20, 4836–4845.
10. Mimura, S., Seki, T., Tanaka, S., and Diffley, J.F.X. (2004). Phosphoryla-
tion-dependent binding of mitotic cyclins to Cdc6 contributes to DNA
replication control. Nature 431, 1118–1123.
11. Elsasser, S., Lou, F., Wang, B., Campbell, J.L., and Jong, A. (1996). Inter-
action between yeast Cdc6 protein and B-type cyclin/Cdc28 kinases.
Mol. Biol. Cell 7, 1723–1735.
12. McGarry, T.J., and Kirschner, M.W. (1998). Geminin, an inhibitor of DNA
replication, is degraded during mitosis. Cell 93, 1043–1053.
13. Amon, A., Irniger, S., and Nasmyth, K. (1994). Closing the cell cycle circle
in yeast: G2 cyclin proteolysis initiated at mitosis persists until the acti-
vation of G1 cyclins in the next cycle. Cell 77, 1037–1050.
14. Ballabeni, A., Melixetian, M., Zamponi, R., Masiero, L., Marinoni, F., and
Helin, K. (2004). Human Geminin promotes pre-RC formation and DNA
replication by stabilizing CDT1 in mitosis. EMBO J. 23, 3122–3132.
15. Kellis, M., Patterson, N., Endrizzi, M., Birren, B., and Lander, E.S. (2003).
Sequencing and comparison of yeast species to identify genes and
regulatory elements. Nature 423, 241–254.
16. Rokas, A., Williams, B.L., King, N., and Carroll, S.B. (2003). Genome-
scale approaches to resolving incongruence in molecular phylogenies.
Nature 425, 798–804.
17. Nguyen, V.Q., Co, C., and Li, J.J. (2001). Cyclin-dependent kinases
prevent DNA re-replication through multiple mechanisms. Nature 411,
1068–1073.
18. Wilmes, G.M., Archambault, V., Austin, R.J., Jacobson, M.D., Bell, S.P.,
and Cross, F.R. (2004). Interaction of the S-phase cyclin Clb5 with an
‘RXL’ docking sequence in the initiator protein Orc6 provides an
origin-localized replication control switch. Genes Dev. 18, 981–991.
19. Tanaka, S., and Diffley, J.F. (2002). Interdependent nuclear accumula-
tion of budding yeast Cdt1 and Mcm2–7 during G1 phase. Nat. Cell
Biol. 4, 198–207.
20. Nash, P., Tang, X., Orlicky, S., Chen, Q., Gertler, F.B., Mendenhall, M.D.,
Sicheri, F., Pawson, T., and Tyers, M. (2001). Multisite phosphorylation
of a CDK inhibitor sets a threshold for the onset of DNA replication.
Nature 414, 514–521.
21. Liku, M.E., Nguyen, V.Q., Rosales, A.W., Irie, K., and Li, J.J. (2005). CDK
phosphorylation of a novel NLS-NES module distributed between two
Diversity in the Regulation of Pre-RC Assembly
535subunits of the Mcm2–7 complex prevents chromosomal rereplication.
Mol. Biol. Cell 16, 5026–5039.
22. Moses, A.M., Liku, M.E., Li, J.J., and Durbin, R. (2007). Regulatory evolu-
tion in proteins by turnover and lineage-specific changes of cyclin-
dependent kinase consensus sites. Proc. Natl. Acad. Sci. USA 104,
17713–17718.
23. Gorr, I.H., Boos, D., and Stemmann, O. (2005). Mutual inhibition of sep-
arase and Cdk1 by two-step complex formation. Mol. Cell 19, 135–141.
24. Kelly, T.J., Martin, G.S., Forsburg, S.L., Stephen, R.J., Russo, A., and
Nurse, P. (1993). The fission yeast cdc18+ gene product couples S
phase to START and mitosis. Cell 74, 371–382.
25. Santocanale, C., and Diffley, J.F.X. (1996). ORC- and Cdc6-dependent
complexes at active and inactive chromosomal replication origins in
Saccharomyces cerevisiae. EMBO J. 15, 6671–6679.
